This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Investigators from multiple institutions conducted a randomized controlled trial assessing the effect of continuous glucose monitoring (CGM) on glycemic control in adolescents and young adults with type 1 diabetes. Participants were 14–24 years old with a duration of diabetes of at least 1 year who had baseline hemoglobin A1c (HbA1c) levels ≥ 7.5% and < 11.0%. At enrollment, study participants were randomized to use CGM or continue with their regular finger stick blood glucose monitoring (BGM). The CGM system included a disposable sensor inserted under the skin that transmitted interstitial glucose levels every 5 minutes to a receiver or smartphone app; twice-daily finger stick glucose levels were required to calibrate the system.
Participants were enrolled in the …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.